These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22489717)

  • 1. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
    Stenvinkel P; Carrero JJ; Axelsson J; Lindholm B; Heimbürger O; Massy Z
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):505-21. PubMed ID: 18184879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk.
    Chmielewski M; Carrero JJ; Stenvinkel P; Lindholm B
    Curr Opin Lipidol; 2009 Feb; 20(1):3-9. PubMed ID: 19133406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
    Stenvinkel P
    Nephrol Ther; 2006 Jul; 2(3):111-9. PubMed ID: 16890135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
    Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in chronic kidney disease: a review.
    Fassett RG; Venuthurupalli SK; Gobe GC; Coombes JS; Cooper MA; Hoy WE
    Kidney Int; 2011 Oct; 80(8):806-21. PubMed ID: 21697815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease.
    Figuer A; Alique M; Valera G; Serroukh N; Ceprían N; de Sequera P; Morales E; Carracedo J; Ramírez R; Bodega G
    Nefrologia (Engl Ed); 2023; 43(1):63-80. PubMed ID: 37268501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project].
    Junyent M; Martínez M; Borrás M; Bertriu A; Coll B; Craver L; Marco MP; Sarró F; Valdivielso JM; Fernández E
    Nefrologia; 2010; 30(1):119-26. PubMed ID: 20098474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in patients with chronic kidney disease. A clinical review.
    Kaisar M; Isbel N; Johnson DW
    Minerva Urol Nefrol; 2007 Sep; 59(3):281-97. PubMed ID: 17912225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Zinc Deficiency with Development of CVD Events in Patients with CKD.
    Nakatani S; Mori K; Shoji T; Emoto M
    Nutrients; 2021 May; 13(5):. PubMed ID: 34063377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular biomarkers in chronic kidney disease.
    Park SH; Stenvinkel P; Lindholm B
    J Ren Nutr; 2012 Jan; 22(1):120-7. PubMed ID: 22200428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.